Ülrike Sommer - Concepedia

Author

Ülrike Sommer

Heidelberg University ORCID

Also Known As

Regina C. Betz, Sommer, U, Sommer, U., Sommer, Ulrike, U Sommer, U. Sommer, Ulrike Sommer, Ülrike Sommer

134

Publications

2.8K

Citations

H-Index

116

Concepts

All Affiliations

Heidelberg University Novartis (Switzerland)Technische Universität Dresden RWTH Aachen University Universitätsklinikum Aachen

ÜS

About

Ülrike Sommer is an author at Heidelberg University specializing in medicine, cell biology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	3	3	95
2	Education	2	2	53
3	Engineering	1	1	23
4	Language Studies	1	1	18
5	Law	1	1	18

Ülrike Sommer

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Olfactory loss may be a first sign of idiopathic Parkinson's disease Antje Haehner, Thomas Hummel, Cornelia Hummel, Movement Disorders	2007	331
Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT Ülrike Sommer, Thomas Hummel, Katja Cormann, Movement Disorders	2004	243
Treatment of Painful Vertebral Fractures by Kyphoplasty in Patients With Primary Osteoporosis: A Prospective Nonrandomized Controlled Study Christian Kasperk, J. Hillmeier, G Nöldge, Journal of Bone and Mineral Research	2005	237
Evidence that a neutrophil–keratinocyte crosstalk is an early target of <scp>IL</scp>‐17A inhibition in psoriasis Kristian Reich, Kim Papp, Robert Matheson, Experimental Dermatology ImmunodeficienciesImmune RegulationImmunologyDermatologyImmune System	2015	197
Tyrosine Phosphorylation Disrupts Elongin Interaction and Accelerates SOCS3 Degradation Serge Haan, Paul Ferguson, Ülrike Sommer, Journal of Biological Chemistry	2003	116
Vascular Endothelial Growth Factor (VEGF)-induced Up-regulation of CCN1 in Osteoblasts Mediates Proangiogenic Activities in Endothelial Cells and Promotes Fracture Healing Darius Schneider, Tanja Keiper, Volker Alt, Journal of Biological Chemistry	2007	99
Nucleocytoplasmic shuttling of persistently activated STAT3 Andreas Herrmann, Michael Vogt, Martin Mönnigmann, Journal of Cell Science ImmunologyMolecular BiologyCellular PhysiologyTumor BiologySignaling Pathway	2007	93
DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function Ildikó Madurka, Alexander Vishnevsky, Joan B. Soriano, Infection New Oral Nlrp3Early Phase 2AAntiviral TherapyRespiratory InfectionInfectious Respiratory Disease	2022	77
Deep-brain stimulation for Parkinson's disease Günther Deuschl, W. Fogel, M. Hahne, Journal of Neurology Stimulation DeviceDeep Brain StimulationNeurophysiologyMedicineNeuroscience	2002	74
Strontium enhances osseointegration of calcium phosphate cement: a histomorphometric pilot study in ovariectomized rats Martin Baier, Patric Staudt, Roman Klein, Journal of Orthopaedic Surgery and Research	2013	71

Page 1